Henry Schein, Inc. (LON:0L3C)
76.18
-1.38 (-1.77%)
Dec 24, 2025, 2:30 PM BST
Henry Schein Market Cap
Henry Schein has a market cap or net worth of 6.65 billion as of December 29, 2025. Its market cap has decreased by -9.08% in one year.
Market Cap
6.65B
Enterprise Value
10.24B
Revenue
9.65B
Ranking
n/a
PE Ratio
22.79
Stock Price
76.18
Market Cap Chart
Since November 3, 1995, Henry Schein's market cap has increased from 263.64M to 6.65B, an increase of 2,420.81%. That is a compound annual growth rate of 11.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 6.65B | -3.57% |
| Dec 31, 2024 | 6.89B | -10.77% |
| Dec 29, 2023 | 7.72B | -14.04% |
| Dec 30, 2022 | 8.99B | 13.16% |
| Dec 31, 2021 | 7.94B | 13.56% |
| Dec 31, 2020 | 6.99B | -5.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.05B |
| GSK plc | 72.45B |
| Haleon | 33.16B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.64B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.71B |
| HUTCHMED (China) | 1.69B |